Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase - PubMed (original) (raw)
. 1997 Nov 14;272(46):29301-8.
doi: 10.1074/jbc.272.46.29301.
Affiliations
- PMID: 9361010
- DOI: 10.1074/jbc.272.46.29301
Free article
Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase
T Soucek et al. J Biol Chem. 1997.
Free article
Abstract
Tuberous sclerosis is an autosomal dominant disorder characterized by the development of benign growths in many tissues and organs. Linkage analysis revealed two disease-determining genes on chromosome 9 and chromosome 16. The TSC2 gene on chromosome 16 encodes a 1784-amino acid tumor suppressor protein, tuberin, that functions as a GTPase-activating protein for Rap1, a member of the superfamily of Ras-related proteins. By immunoblot analyses, we found TSC2 expression to be high in G0 as well as in early small G1 cells. Analyses after different cell synchronization procedures revealed that TSC2 mRNA and protein expression do not fluctuate throughout the cell cycle. Using inducible expression systems we further demonstrated that TSC2 expression is not affected by overexpression of the mitogenic transcription factor E2F-1 or c-Myc. Nevertheless, antisense inhibition of tuberin expression in logarithmically growing cells markedly decreased the percentage of cells in G1. Furthermore, we found that cells exposed to TSC2 antisense oligonucleotides did not undergo G0 arrest after serum withdrawal. Antisense inhibition of TSC2 expression also induced quiescent G0-arrested fibroblasts to reenter the cell cycle. Our data show for the first time that the absence of tuberin can both induce cells to pass through the G1/S transition of the eukaryotic cell cycle and prevent them from entering a quiescent state. These results have clear implications for the tumor suppressor function of TSC2. We further found that reentry into the cell cycle upon loss of TSC2 is dependent on the activity of the G1 cyclin-dependent kinases (CDKs), Cdk2 or Cdk4. Taken together with our finding that antisense inhibition of TSC2 causes up-regulation of cyclin D1 expression, these results provide the first evidence for a connection between tuberin/Rap1 and the G1 CDK-dependent regulation of the transition from G0/G1 to S phase.
Similar articles
- Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
Soucek T, Yeung RS, Hengstschläger M. Soucek T, et al. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15653-8. doi: 10.1073/pnas.95.26.15653. Proc Natl Acad Sci U S A. 1998. PMID: 9861025 Free PMC article. - The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM, Cheadle JP, Jones AC, Myring J, Fryer AE, Harris PC, Sampson JR. Maheshwar MM, et al. Hum Mol Genet. 1997 Oct;6(11):1991-6. doi: 10.1093/hmg/6.11.1991. Hum Mol Genet. 1997. PMID: 9302281 - Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F, Wienecke R, Xiao GH, Maize JC Jr, DeClue JE, Yeung RS. Jin F, et al. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9154-9. doi: 10.1073/pnas.93.17.9154. Proc Natl Acad Sci U S A. 1996. PMID: 8799170 Free PMC article. - Tuberous sclerosis gene products in proliferation control.
Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M. Hengstschläger M, et al. Mutat Res. 2001 Jul;488(3):233-9. doi: 10.1016/s1383-5742(01)00058-8. Mutat Res. 2001. PMID: 11397651 Review. - Molecular genetic advances in tuberous sclerosis.
Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Cheadle JP, et al. Hum Genet. 2000 Aug;107(2):97-114. doi: 10.1007/s004390000348. Hum Genet. 2000. PMID: 11030407 Review.
Cited by
- Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.
Fang F, Sun S, Wang L, Guan JL, Giovannini M, Zhu Y, Liu F. Fang F, et al. J Bone Miner Res. 2015 Jul;30(7):1195-205. doi: 10.1002/jbmr.2447. J Bone Miner Res. 2015. PMID: 25639352 Free PMC article. - Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.
Bhatia B, Northcott PA, Hambardzumyan D, Govindarajan B, Brat DJ, Arbiser JL, Holland EC, Taylor MD, Kenney AM. Bhatia B, et al. Cancer Res. 2009 Sep 15;69(18):7224-34. doi: 10.1158/0008-5472.CAN-09-1299. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738049 Free PMC article. - TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.
Gao X, Pan D. Gao X, et al. Genes Dev. 2001 Jun 1;15(11):1383-92. doi: 10.1101/gad.901101. Genes Dev. 2001. PMID: 11390358 Free PMC article. - ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD, Gard JM, Nagle RB, Dietrich JD, Monks TJ, Lau SS. Cohen JD, et al. Toxicol Sci. 2011 Nov;124(1):75-87. doi: 10.1093/toxsci/kfr203. Epub 2011 Aug 2. Toxicol Sci. 2011. PMID: 21813464 Free PMC article. - c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation.
Ravitz MJ, Chen L, Lynch M, Schmidt EV. Ravitz MJ, et al. Cancer Res. 2007 Dec 1;67(23):11209-17. doi: 10.1158/0008-5472.CAN-06-4351. Cancer Res. 2007. PMID: 18056446 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials